engleski

Comparison of evening and morning dosing of travoprost 0, 004%/timlol 0, 5% fixed combination in 6-month period

An open label, multi-center 6 month observationa study of new fixed combination travoprost 0, 004%/timolol 0, 5% in order to evaluate both efficacy and tolerability of two dosing regimens- evening and morning. This fixed combination proved sufficient intraocular pressure control dosed either in the evening or in the morning with no statistically significant difference between two dosing regimens.

travoprost 0 ; 004%/timolol 0 ; 5% ; glaucoma ; dosing regimen

nije evidentirano